Followers | 854 |
Posts | 34459 |
Boards Moderated | 17 |
Alias Born | 03/22/2016 |
Monday, January 22, 2024 9:36:59 AM
Recent TNYA News
- Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones • GlobeNewswire Inc. • 01/13/2025 02:16:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 12:58:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 12:24:29 PM
- Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy • GlobeNewswire Inc. • 12/17/2024 12:00:00 PM
- Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024 • GlobeNewswire Inc. • 12/16/2024 09:30:00 PM
- Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy • GlobeNewswire Inc. • 11/25/2024 01:30:00 PM
- Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/19/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2024 01:48:18 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2024 09:20:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:16:43 PM
- Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/06/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/22/2024 12:40:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/22/2024 12:35:49 AM
- Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM • GlobeNewswire Inc. • 10/17/2024 08:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/17/2024 10:26:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:05:40 PM
- Tenaya Therapeutics to Participate in Upcoming Investment Conferences • GlobeNewswire Inc. • 09/03/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:30:38 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:23:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/17/2024 12:26:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/17/2024 12:24:32 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:24:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:14:41 PM
- Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
UAV Corp Skyborne Technology Secures $105M in Sales Contract LOIs for Revolutionary DART Series Airships • UMAV • Jan 13, 2025 11:00 AM
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) • SNWV • Jan 13, 2025 8:10 AM
SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales • SNWV • Jan 13, 2025 8:08 AM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • BLO • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM